Asymptomatic bacteriuria in users of low-dose combined oral contraceptives

By Nassaji Mohammad   Ghorbani Raheb  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 4, 2011-08 ,pp. : 307-310

Informa Healthcare

Access to resources Recommend Favorite

Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function

By Vogelvang T.E.   van der Mooren M.J.   Kamp O.   Mijatovic V.   Visser C.A.   Kenemans P.  

Fertility and Sterility, Vol. 80, Iss. 3, 2003-09 ,pp. : 546-553

Elsevier

Access to resources Recommend Favorite

A pharmacokinetic study with a low-dose oral contraceptive containing 20 μg ethinylestradiol plus 100 μg levonorgestrel

By Endrikat J.   Blode H.   Gerlinger C.   Rosenbaum P.   Kuhnz W.  

The European Journal of Contraception and Reproductive Health Care, Vol. 7, Iss. 2, 2002-06 ,pp. : 79-90

Informa Healthcare

Access to resources Recommend Favorite

Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use

By Rad Mandana   Kluft Cornelis   de Kam Marieke L.   Meijer Piet   Cohen Adam F.   Grubb Gary S.   Constantine Ginger D.   Burggraaf Jacobus  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 2, 2011-04 ,pp. : 85-94

Informa Healthcare

Access to resources Recommend Favorite

Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy

By Moosavi AS   Gilani MM   Tehranian A   Esfahani JK  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 3, 2004-04 ,pp. : 292-293

Informa Healthcare

Access to resources Recommend Favorite